We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+2.16%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$119M
AUM Growth
+$3.11M
Cap. Flow
+$619K
Cap. Flow %
0.52%
Top 10 Hldgs %
22.99%
Holding
184
New
25
Increased
49
Reduced
67
Closed
21

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$1.48M
2
ADI icon
Analog Devices
ADI
+$1.13M
3
PRXL
Parexel International Corp
PRXL
+$1.1M
4
MSFT icon
Microsoft
MSFT
+$969K
5
JWN
Nordstrom
JWN
+$833K

Sector Composition

Rank Sector Weight
1 Industrials 18.45%
2 Healthcare 16.9%
3 Consumer Staples 13.84%
4 Financials 13.02%
5 Consumer Discretionary 11.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEP icon
51
PepsiCo
PEP
$190B
$765K 0.64%
7,029
+630
+10% +$67.9K
PNR icon
52
Pentair
PNR
$11B
$752K 0.63%
17,421
+2,047
+13% +$86.3K
AKAM icon
53
Akamai
AKAM
$15.9B
$742K 0.62%
14,005
-900
-6% -$48.2K
RTX icon
54
RTX Corp
RTX
$301B
$718K 0.6%
11,234
IBP icon
55
Installed Building Products
IBP
$6.49B
$714K 0.6%
+19,900
New +$692K
HRL icon
56
Hormel Foods
HRL
$13.8B
$713K 0.6%
18,800
+4,550
+32% +$169K
GILD icon
57
Gilead Sciences
GILD
$165B
$703K 0.59%
8,890
+5,625
+172% +$457K
UNP icon
58
Union Pacific
UNP
$174B
$703K 0.59%
7,213
-2,325
-24% -$217K
AWI icon
59
Armstrong World Industries
AWI
$7.84B
$696K 0.58%
16,850
-1,200
-7% -$50.2K
EPD icon
60
Enterprise Products Partners
EPD
$81.7B
$690K 0.58%
24,980
+12,925
+107% +$357K
TGT icon
61
Target
TGT
$68B
$690K 0.58%
10,050
+5,650
+128% +$405K
ZTS icon
62
Zoetis
ZTS
$30B
$686K 0.58%
13,195
+2,350
+22% +$119K
HBI
63
DELISTED
Hanesbrands
HBI
$684K 0.57%
27,100
-400
-1% -$10.5K
AAL icon
64
American Airlines Group
AAL
$10.6B
$653K 0.55%
17,825
-1,700
-9% -$60.1K
MHK icon
65
Mohawk Industries
MHK
$9.22B
$651K 0.55%
3,250
-3,970
-55% -$816K
ACM icon
66
Aecom
ACM
$9.75B
$638K 0.53%
+21,450
New +$691K
LEN icon
67
Lennar Class A
LEN
$21.2B
$634K 0.53%
15,732
-1,445
-8% -$64K
JPM.PRD.CL
68
DELISTED
JPMorgan Chase & Co.
JPM.PRD.CL
$628K 0.53%
24,300
+1,000
+4% +$26K
CP icon
69
Canadian Pacific Kansas City
CP
$80.5B
$616K 0.52%
20,185
-2,250
-10% -$66.1K
AVNS
70
DELISTED
Avanos Medical
AVNS
$612K 0.51%
17,657
+4,200
+31% +$147K
PANW icon
71
Palo Alto Networks
PANW
$297B
$586K 0.49%
22,074
-3,450
-14% -$78.6K
LYB icon
72
LyondellBasell Industries
LYB
$19.2B
$581K 0.49%
7,200
+450
+7% +$34.8K
KO icon
73
Coca-Cola
KO
$375B
$579K 0.49%
13,673
PDCO
74
DELISTED
Patterson Companies, Inc.
PDCO
$577K 0.48%
+12,568
New +$595K
UPS icon
75
United Parcel Service
UPS
$88.9B
$558K 0.47%
5,100
-200
-4% -$21.8K

Similar funds

New England Research & Management's Q3 2016 Portfolio in Review

As of Q3 2016, New England Research & Management held 184 positions worth $119M, up 2.7% from $116M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

New England Research & Management's Q3 2016 filing shows 25 new, 49 increased, 67 reduced and 21 closed positions. Its largest new stake was Installed Building Products: 19,900 shares worth $714K. The largest sale was Merck, an estimated $1.48M.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Staples.

  • New England Research & Management's largest Q3 2016 buy was Installed Building Products: 19,900 shares worth $714K.
  • New England Research & Management added most to Bristol-Myers Squibb in Q3 2016, an estimated $881K increase.
  • New England Research & Management's biggest Q3 2016 reduction was Merck, cutting an estimated $1.48M.
  • New England Research & Management fully exited Analog Devices in Q3 2016, selling an estimated $1.13M.
  • New England Research & Management's ten largest holdings make up 23% of its $119M portfolio in Q3 2016.
  • New England Research & Management opened 25 new positions and closed 21 in Q3 2016.
  • New England Research & Management's portfolio value rose 2.7% quarter-over-quarter to $119M.

Based on New England Research & Management's 13F filing for Q3 2016, filed 5 Oct 2016.